Skip to main content

Table 1 Treatment dosing regimen

From: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE)

Arm

Total daily dosage

Regimen

Total No of tablets daily

FAVI active + nitazoxanide active

Day 1:

FAVI = 3600mg

FAVI:

1st dose: 1800mg (9 tablets) 2nd dose: 1800mg (9 tablets)

Day 1:

FAVI = 18 tablets

OR

FAVI active + nitazoxanide placebo

PLUS

PLUS

PLUS

 

NITA = 1000 mg

LPV/r:

1st dose: 1000mg (2 tablets)

2nd dose: 1000mg (2 tablets)

NITA = 4 tablets

 

Day 2 to day 7:

FAVI = 1600mg

FAVI:

1st dose: 400mg (2 tablets)

2nd dose: 400mg (2 tablets)

3rd dose: 400mg (2 tablets)

4th dose: 400mg (2 tablets)

Day 2 to Day 7:

FAVI = 8 tablets

 

PLUS

PLUS

PLUS

 

NITA = 500mg

NITA:

1st dose: 500mg (1 tablet)

2nd dose: 500mg (1 tablet)

3rd dose: 500mg (1 tablet)

4th dose: 500mg (1 tablet)

NITA = 4 tablets